by Lee Ji-yoon
Published : Sept. 14, 2026 - 13:58:44
SK Biopharm disclosed Monday that it signed a pharmaceutical supply contract with its subsidiary SK Life Science.
The contract is valued at 71.59 billion won ($53.2 million), equivalent to 10.1 percent of the company's 2025 sales.
The contract runs through Friday.
This content was produced with the assistance of AI translation services.
Kakao Maps to show real-time ferry locations by the second
Sept. 15, 2026
Trump pushes back on AI slowdown calls, vows to 'keep it that way'
Sept. 14, 2026
Michelin launches two new tires to end the performance-vs-efficiency debate
Sept. 15, 2026
APR says hair-loss treatment research published in international journal
Sept. 14, 2026
A terminal cancer father's essays find life in print — the story behind 'Goodbye, Peter Pan'
July 3, 2026
